GIA
ABMD

Gateway Investment Advisers’s Abiomed Inc ABMD Stock Holding History

Gateway Investment Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,670
Closed -$435K – 665
2019
Q2 		$435K Sell
1,670
-76
-4% -$20.2K ﹤0.01% 584
2019
Q1 		$499K Sell
1,746
-83
-5% -$27.6K ﹤0.01% 570
2018
Q4 		$594K Buy
1,829
+99
+6% +$34.4K 0.01% 526
2018
Q3 		$778K Sell
1,730
-104
-6% -$41K 0.01% 503
2018
Q2 		$750K Buy
+1,834
New +$664K 0.01% 510

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Gateway Investment Advisers's ABMD Position: Q3 2019 in Review

Gateway Investment Advisers sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,670 shares — an estimated $435K sold.

Gateway Investment Advisers first reported a position in ABMD in Q2 2018 and held it in 5 quarters. The position peaked at $778K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Gateway Investment Advisers reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Gateway Investment Advisers sold 1,670 Abiomed Inc shares in Q3 2019, an estimated $435K.
  • Gateway Investment Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 5 quarters.
  • Gateway Investment Advisers's Abiomed Inc position peaked at $778K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Gateway Investment Advisers's 13F filing for Q3 2019, filed 15 Oct 2019.